CompletedPhase 2NCT00005675

Oral Type I Collagen for Relieving Scleroderma

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Principal Investigator: Arnold E. Postlethwaite, MD
University of Tennessee at Memphis
Intervention: Oral bovine type I collagen(drug)
Enrollment: 168 enrolled
Eligibility: 18 years · All sexes
Timeline: 2000

Study locations (12)

University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California Los Angeles, Los Angeles, California, United States
University of Connecticut, Farmington, Connecticut, United States
Georgetown University Medical Center, Washington D.C., District of Columbia, United States
Johns Hopkins University, Baltimore, Maryland, United States
Boston University School Of Medicine, Boston, Massachusetts, United States
Wayne State University, Detroit, Michigan, United States
Beth Israel Medical Center, New York, New York, United States
Medical University of South Carolina, Charleston, South Carolina, United States
University of Tennessee Health Science Center, Memphis, Tennessee, United States
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Virginia Mason Research Center, Seattle, Washington, United States

Collaborators

Wayne State University · University of California, Los Angeles · UTHSC · Medical University of South Carolina · Beth Israel Medical Center · University of Alabama at Birmingham · Johns Hopkins University · Georgetown University · Baltimore VA Medical Center · Northwestern University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00005675 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials